Gene · 11343
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network Pharmacology-Driven Sustainability: AI and Multi-Omics Synergy for Drug Discovery in Traditional Chinese Medicine. | Pharmaceuticals (Basel) | 2025 | 40732361 | PubTator, text mining | PubMed |
| Construction and Brain Validation of circRNAs-miRNAs-mRNAs Regulatory Axis in Early-Onset Schizophrenia. | Neuropsychiatr Dis Treat | 2025 | 40726542 | PubTator, text mining | PubMed |
| Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy. | Int J Mol Sci | 2025 | 40650012 | PubTator, text mining | PubMed |
| Cistanoside F acts as a Monoacylglycerol Lipase inhibitor that synergizes the anti-tumor effect of 2-Arachidonoyl Glycerol on Bladder cancer. | Phytomedicine | 2025 | 40645071 | PubTator, text mining | PubMed |
| The endocannabinoidome-gut microbiome-brain axis as a novel therapeutic target for autism spectrum disorder. | J Biomed Sci | 2025 | 40605060 | PubTator, text mining | PubMed |
| Deciphering the interaction between N-palmitoyl-D-glucosamine and the endocannabinoidome. | Sci Rep | 2025 | 40596256 | PubTator, text mining | PubMed |
| Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold. | Bioorg Chem | 2025 | 40554889 | PubTator, text mining | PubMed |
| Integrated network toxicology and population-based analysis uncovers organophosphate flame retardant exposure as a risk factor for hepatic steatosis and fibrosis: mechanistic and clinical insights. | Int J Surg | 2025 | 40540538 | PubTator, text mining | PubMed |
| Twin Study Provides Heritability Estimates for 2321 Plasma Proteins and Assesses Missing SNP Heritability. | J Proteome Res | 2025 | 40425507 | PubTator, text mining | PubMed |
| Identifying a novel class of lead compounds for monoacylglycerol lipase inhibition: an integrated computational study. | Cell Mol Biol (Noisy-le-grand) | 2025 | 40418543 | PubTator, text mining | PubMed |
| Flavonoid carbamate hybrids: design, synthesis, and evaluation as multi-target enzyme inhibitors for Alzheimer's disease. | RSC Adv | 2025 | 40395797 | PubTator, text mining | PubMed |
| The endocannabinoid system in cancer biology: a mini-review of mechanisms and therapeutic potential. | Oncol Rev | 2025 | 40370489 | PubTator, text mining | PubMed |
| A novel approach for modeling in vivo enzyme turnover in the presence of a suicide inhibitor drug: A proof-of-concept brain PET study on MAG lipase. | J Cereb Blood Flow Metab | 2025 | 40370302 | PubTator, text mining | PubMed |
| Disrupting lipid homeostasis with CAV2 in OSCC triggers apoptosis, lipolysis, and mitochondrial dysfunction by transcriptional repression of PPARγ. | Cell Biosci | 2025 | 40369665 | PubTator, text mining | PubMed |
| Correction: Inhibition of endocannabinoid hydrolases MAGL, FAAH and ABHD6 by AKU‑005 reduces ex vivo cortical spreading depression. | J Headache Pain | 2025 | 40350420 | PubTator, text mining | PubMed |
| Identification of GALNT12 as a Novel Potential Diagnostic and Prognostic Marker for Esophageal Squamous Cell Carcinoma by Integrated Bioinformatics Analysis. | Digestion | 2025 | 40334654 | PubTator, text mining | PubMed |
| Effect of dexamethasone on biological properties and metabolic adaptations of normal prostate epithelial cells under mild serum conditions. | Steroids | 2025 | 40316041 | PubTator, text mining | PubMed |
| Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development. | Molecules | 2025 | 40286255 | PubTator, text mining | PubMed |
| Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets. | Chem Res Toxicol | 2025 | 40253625 | PubTator, text mining | PubMed |
| AUP1 and UBE2G2 complex targets STING signaling and regulates virus-induced innate immunity. | mBio | 2025 | 40237449 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11343/papers?page=6